About This 510(k) Submission
K233159 is an FDA 510(k) clearance for the pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW 504, a Dialysate Concentrate For Hemodialysis (liquid Or Powder) (Class II — Special Controls, product code KPO), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on December 1, 2023, 65 days after receiving the submission on September 27, 2023. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5820.